These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27660942)

  • 1. Universalis Calcinosis in Adult Dermatomyositis: An "Anti-NXP2 Syndrome".
    Fodil D; Meyer A; Salah SS; Sibilia J; Attal N; Tafiani-Lefkir S
    J Clin Rheumatol; 2016 Oct; 22(7):387-9. PubMed ID: 27660942
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.
    Tansley SL; Betteridge ZE; Shaddick G; Gunawardena H; Arnold K; Wedderburn LR; McHugh NJ;
    Rheumatology (Oxford); 2014 Dec; 53(12):2204-8. PubMed ID: 24987158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous immunoglobulin for the treatment of calcinosis associated with juvenile dermatomyositis.
    Rodríguez-Lozano AL; Mata-Aguilera X; Rivas-Larrauri F; Bustamante-Ogando JC; Gutierrez-Hernandez A; Bojalil-Cabildo A; Scheffler-Mendoza S; Yamazaki-Nakashimada M
    Int J Rheum Dis; 2024 Jun; 27(6):e15239. PubMed ID: 38923294
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options.
    Fredi M; Bartoli F; Cavazzana I; Ceribelli A; Carabellese N; Tincani A; Satoh M; Franceschini F
    Clin Exp Rheumatol; 2017; 35(2):303-308. PubMed ID: 27908312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcinosis universalis in adult-onset dermatomyositis.
    Bernardino V; Rodrigues A; Panarra A; Riso N
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26272968
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-NXP2 antibody-associated extensive subcutaneous calcinosis in adult-onset myositis.
    Goulabchand R; Guilpain P; Cyteval C; Le Quellec A
    Rheumatology (Oxford); 2017 Oct; 56(10):1661. PubMed ID: 28605526
    [No Abstract]   [Full Text] [Related]  

  • 7. Pemphigus foliaceus associated with anti-NXP2 autoantibody-positive dermatomyositis.
    Fujimoto N; Takayama S; Hamaguchi Y; Fujimoto M; Tanaka T
    Acta Derm Venereol; 2014 Jul; 94(4):478-9. PubMed ID: 24217940
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dermatomyositis-specific antibodies].
    Bodoki L; Nagy-Vincze M; Griger Z; Dankó K
    Z Rheumatol; 2015 May; 74(4):363-9. PubMed ID: 25644067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of polymyositis and dermatomyositis.
    Targoff IN
    Compr Ther; 1990 Apr; 16(4):16-24. PubMed ID: 2185913
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dermatomyositis].
    Basset A; Maleville J; Bergoend H; Grosshans E; Heid E; Schubert B; Vetter JM
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(2):165-6. PubMed ID: 5128255
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and therapeutic aspects of dermatomyositis in childhood].
    Garibaldi LR; Battistini E
    Minerva Pediatr; 1978 Nov; 30(22):1793-5. PubMed ID: 723825
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution of the Interferon score in the management of an anti-NXP2 dermatomyositis patient with calcinosis successfully treated with tofacitinib.
    Robert M; Gallay L; Garnier L; Pescarmona R; Hot A
    Joint Bone Spine; 2023 Jul; 90(4):105532. PubMed ID: 36706944
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous features of dermatomyositis associated with myositis-specific antibodies.
    Daly ML; Gordon PA; Creamer D
    Br J Dermatol; 2017 Jun; 176(6):1662-1665. PubMed ID: 27579700
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-NXP2-Positive Paraneoplastic Dermatomyositis With Histopathologic Changes Confined to the Acrosyringia.
    Ramírez-Bellver JL; Macías E; Bernárdez C; López-Robles J; Vegas-Sánchez MD; Díaz-Recuero JL; Quiceno H; Requena L
    Am J Dermatopathol; 2017 Jan; 39(1):e3-e7. PubMed ID: 28045754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe adult dermatomyositis with unusual calcinosis.
    Garel B; Barète S; Rigolet A; Le Pelletier F; Benveniste O; Hervier B
    Rheumatology (Oxford); 2015 Nov; 54(11):2024. PubMed ID: 26286744
    [No Abstract]   [Full Text] [Related]  

  • 16. Complete and sustained resolution of calcinosis universalis in a juvenile dermatomyositis case with mycophenolate mofetil.
    Çakan M; Karadağ ŞG; Ayaz NA
    Turk J Pediatr; 2019; 61(5):771-775. PubMed ID: 32105011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of juvenile dermatomyositis with calcinosis universalis--remarkable improvement with aluminum hydroxide therapy].
    Aihara Y; Mori M; Ibe M; Kuriyama T; Takahashi Y; Shimizu C; Shike H; Mitsuda T; Yokota S
    Ryumachi; 1994 Oct; 34(5):879-84. PubMed ID: 7801200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to nuclear matrix protein 2/MJ in adult-onset dermatomyositis with severe calcinosis.
    Sugiura K; Muro Y; Akiyama M
    J Am Acad Dermatol; 2012 Oct; 67(4):e167-8. PubMed ID: 22980285
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic Calcinosis in NXP2-Dermatomyositis.
    Martín D; Curbelo J; Moldenhauer F
    J Clin Rheumatol; 2019 Jun; 25(4):e35. PubMed ID: 29319550
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-TIF1-γ autoantibodies-positive dermatomyositis: where is the malignancy?
    Zachou A; Zouvelou V; Papadimas GK; Rentzos M; Papadopoulos C
    Rheumatology (Oxford); 2018 Apr; 57(4):756. PubMed ID: 28968891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.